Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In this double-blind trial, we randomly assigned patients with Chronic Renal Failure / Chronic Kidney Disease (CKD) and type 2 diabetes to receive finerenone or placebo.
Primary outcome measures:
The First Occurrence of the Composite Endpoint of Cardiovascular Death, Non-fatal Myocardial Infarction, Non Fatal Stroke, or Hospitalization for Heart Failure.
The authors' conclusion was: Among patients with type 2 diabetes and stage 2 to 4 Chronic Renal Failure / Chronic Kidney Disease (CKD) with moderately elevated…